Teradyne, Inc. filings document an operating company with common stock traded on Nasdaq under TER and businesses in automated test equipment and advanced robotics. Form 8-K reports cover quarterly operating and financial results across Semiconductor Test, Product Test, and Robotics, along with material events such as annual meeting vote results and executive-transition or compensation arrangements.
Proxy materials describe board elections, advisory compensation votes, auditor ratification, executive compensation, equity-award reporting, and related governance matters. The filings also provide capital-structure details, including Teradyne's common stock class, and formal exhibits tied to earnings releases and other disclosure events.
TER submitted a Form 144 notice to sell 8,597 shares of Common Stock via Fidelity Brokerage Services LLC. The filing lists specific sale/vesting events tied to restricted stock vesting on 01/28/2026 and 02/01/2026, and an options-related item dated 05/15/2026. The filing names NASDAQ as the market and references cash proceeds for the options‑related item.
Herweck Peter reported acquisition or exercise transactions in this Form 4 filing.
Teradyne, Inc. director Peter Herweck received a grant of 668 restricted stock units (RSUs) of Common Stock. The award was granted under Teradyne's 2006 Equity and Cash Compensation Incentive Plan as a form of equity compensation rather than a cash purchase.
Each RSU represents the right to receive one share of Common Stock. The RSUs are time-based and will vest in full on the earlier of May 8, 2027 or the date of Teradyne's 2027 Annual Meeting of Shareholders. After this grant, Herweck directly holds 16,134 shares of Common Stock.
TERADYNE, INC director Mercedes Johnson reported a routine equity compensation grant. She received 668 shares of Common Stock as restricted stock units under the company’s 2006 Equity and Cash Compensation Incentive Plan, bringing her direct holdings to 7,031 shares.
The RSUs are time-based and will vest in full on the earlier of May 8, 2027 or the date of Teradyne’s 2027 Annual Meeting of Shareholders. Johnson also reports 1,876 shares held indirectly through The Mercedes Johnson Trust, where she serves as trustee and sole beneficiary. The filing shows an acquisition of shares as compensation, with no open-market buying or selling.
MATZ MARILYN reported acquisition or exercise transactions in this Form 4 filing.
Teradyne director Marilyn Matz reported a stock-based compensation grant. On May 8, 2026, she received 668 restricted stock units (RSUs), each representing one share of Teradyne common stock, at no cash cost as a grant or award. These time-based RSUs vest in full on the earlier of May 8, 2027 or the company’s 2027 Annual Meeting of Shareholders. Following this award, Matz’s directly held common stock position reported in the filing is 19,840.675 shares. This is a routine equity compensation grant rather than an open-market purchase.
van Kralingen Bridget A reported acquisition or exercise transactions in this Form 4 filing.
Teradyne director Bridget A. van Kralingen received an equity award in the form of restricted stock units. She was granted 668 RSUs of Teradyne common stock at no cash cost as compensation, increasing her directly held stake to 6,224 shares.
Each RSU equals one share of common stock. The award is time-based and will vest in full on the earlier of May 8, 2027 or the date of Teradyne’s 2027 Annual Meeting of Shareholders, aligning her compensation with future company performance and service.
TERADYNE, INC director Paul J. Tufano received an equity grant of 668 restricted stock units. The award was granted at no cash cost to him and was made under Teradyne’s 2006 Equity and Cash Compensation Incentive Plan. Each RSU converts into one share of common stock and will vest in full on the earlier of May 8, 2027 or the company’s 2027 Annual Meeting of Shareholders. Following this grant, Tufano directly holds 65,713 shares of Teradyne common stock.
Sayiner Necip reported acquisition or exercise transactions in this Form 4 filing.
Teradyne, Inc. director Necip Sayiner received an equity grant of 668 restricted stock units (RSUs), each representing one share of common stock, as compensation. The award was granted at no cash cost and comes under the company’s 2006 Equity and Cash Compensation Incentive Plan.
The RSUs are time-based and will vest in full on the earlier of May 8, 2027 or the date of Teradyne’s 2027 Annual Meeting of Shareholders. Following this grant, Sayiner’s reported direct holdings total 2,800 shares of common stock, reflecting a relatively small, routine compensation-related increase in his stake.
MADDOCK ERNEST E reported acquisition or exercise transactions in this Form 4 filing.
TERADYNE, INC director Ernest E. Maddock reported a compensation-related stock award. He received 668 restricted stock units (RSUs) of Common Stock under the company’s 2006 Equity and Cash Compensation Incentive Plan, with no purchase price.
Each RSU represents one share of Teradyne common stock. The RSUs are time-based and will vest in full on the earlier of May 8, 2027 or the date of Teradyne’s 2027 Annual Meeting of Shareholders. Following this grant, Maddock directly holds 10,265 shares of common stock.
Henry Andrew Chisholm reported acquisition or exercise transactions in this Form 4 filing.
Teradyne, Inc. director Henry Andrew Chisholm received a grant of 668 restricted stock units (RSUs), each representing one share of common stock. These time-based RSUs vest in full on the earlier of May 8, 2027 or the company’s 2027 annual shareholder meeting. Following this grant, he holds 2,875 shares directly.